Brentuximab vedotin plus CHP-like versus CHOEP regimen for the first-line treatment of PTCL patients: a multi-center propensity-matched retrospective study

IntroductionThe optimal frontline treatment option for Peripheral T-cell lymphomas (PTCLs) has not been completely defined.MethodsTo compare the efficacy and safety of brentuximab vedotin (BV) combined with CHP-like regimen (cyclophosphamide, an anthra…

Longitudinal cytokines in plasma extracellular vesicle enriched preparations and motor worsening in Parkinson disease

IntroductionInflammation is implicated in Parkinson disease (PD), but the prognostic value of circulating cytokines beyond clinical information remains incompletely defined.MethodsWe studied cytokines measured in polymer-precipitated plasma extracellul…

Inducible and reversible in vivo protein degradation reveals T cell-intrinsic regulatory function of SHP-1

Scientific problemStudying the acute, cell-intrinsic functions of signaling proteins in T cells has long been challenging. Existing constitutive or inducible gene deletion cannot overcome developmental adaptation that obscures true phenotypes. Similarl…

Interferon regulatory factor 1: a key transcriptional node orchestrating macrophage polarization: mechanisms and therapeutic potential

Macrophageexhibit remarkable functional plasticity and adopt M1-like pro-inflammatory or M2-like anti-inflammatory/pro-resolving states in response to microenvironmental stimuli. Notably, this binary functional classification originates largely from in…

Eribulin mesylate in combination with ivonescimab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer(EMIT): study protocol for a single-arm, multicenter clinical trial

BackgroundAdvanced triple-negative breast cancer (TNBC) has an extremely poor prognosis, and current therapies offer limited benefits for patients with low programmed cell death ligand 1(PD-L1) expression. This study innovatively proposes a “novel chem…

Integrating proteomics to map immune landscape and protein biomarkers for risk stratification in childhood Langerhans cell histiocytosis

BackgroundLangerhans cell histiocytosis (LCH) is a rare pediatric disease with marked clinical heterogeneity. Current risk stratification relies on the extent of organ involvement and risk-organ status, yet reliable protein biomarkers for distinguishin…

Large-scale plasma proteomics identifies proteins and pathways associated with incident interstitial lung disease

ObjectiveReliable biomarkers for early interstitial lung disease (ILD) risk stratification are limited; therefore, we aimed to identify prediagnostic proteins associated with incident ILD and develop a long-term prediction model.MethodsWe analyzed 52,7…

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri cURL Hatası: Could not resolve host: lkl.dolarkurum.com